FDA reorganized the Commissioner’s Office, effective March 31, 2019. As part of that reorganization, FDA’s Office of International Programs was augmented and redesigned to become the Office of Global Policy and Strategy (OGPS) within FDA’s Office of Policy, Legislation and International Affairs. OGPS is led by Associate Commissioner Mark Abdoo and has three sub-offices: Global Operations, which includes our foreign posts; Global Diplomacy and Partnerships; and Trade, Mutual Recognition and International Arrangements. FDA views this reorganization as a critical step in further elevating its international endeavors, ensuring that this work is fully integrated into and across the agency’s strategic engagements and key policy initiatives.
This organization chart reflects the new structure under which FDA will operate.
A fuller explanation of FDA Globalization initiatives can be found on the International Programs - Globalization page
- Remarks at the AFDO 2018 Conference, International and Government Relations Committee Meeting
- Remarks for the International Regulatory Convergence Panel